Correlation Between MannKind Corp and Ascendis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MannKind Corp and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MannKind Corp and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MannKind Corp and Ascendis Pharma AS, you can compare the effects of market volatilities on MannKind Corp and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MannKind Corp with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MannKind Corp and Ascendis Pharma.

Diversification Opportunities for MannKind Corp and Ascendis Pharma

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between MannKind and Ascendis is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding MannKind Corp and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and MannKind Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MannKind Corp are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of MannKind Corp i.e., MannKind Corp and Ascendis Pharma go up and down completely randomly.

Pair Corralation between MannKind Corp and Ascendis Pharma

Given the investment horizon of 90 days MannKind Corp is expected to under-perform the Ascendis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, MannKind Corp is 1.4 times less risky than Ascendis Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Ascendis Pharma AS is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  12,944  in Ascendis Pharma AS on August 28, 2024 and sell it today you would earn a total of  141.00  from holding Ascendis Pharma AS or generate 1.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MannKind Corp  vs.  Ascendis Pharma AS

 Performance 
       Timeline  
MannKind Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, MannKind Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

MannKind Corp and Ascendis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MannKind Corp and Ascendis Pharma

The main advantage of trading using opposite MannKind Corp and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MannKind Corp position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.
The idea behind MannKind Corp and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk